PatientView

CALL TO PATIENT GROUPS Now Launched: Corporate Reputation of Pharma 2024/5 PatientView's annual survey, open to patient groups worldwide and available in 23 languages, is now open to responses. Now in its 14th year, this survey builds on two decades of experience. With 46 pharma companies involved, this report is an opportunity for patient groups to voice their opinions on the pharmaceutical industry's performance and reputation in 2024, and help enact real change for patient care. Surveys available in 23 languages at the link below: https://lnkd.in/eS-x_xbj #pharma #patientview #patientcare #patientadvocacy

Queremos ouvir os grupos de pacientes de todo o mundo, especialmente da Brazil. O PatientView o convida a dar sua opinião sobre a indústria farmacêutica.  👉 https://lnkd.in/eUgTfRJR É hora de fazer com que sua voz seja ouvida. Participe agora  👉 https://lnkd.in/eUgTfRJR Suas respostas são muito importantes para descobrir se as empresas farmacêuticas atenderam às suas necessidades e expectativas em 2024 e para saber sua opinião sobre o que o setor deve fazer em 2025. A pesquisa é curta e você pode respondê-la de forma totalmente anônima. Nós lhe enviaremos uma cópia gratuita dos resultados da pesquisa assim que forem publicados. Muito obrigado por participar!   #industriaFarmaceutica #pacientes #Brasil #Saude #medicina #medicamentos #cancer #diabetes #saudePublica

Over 1,500 patient groups are sharing their opinions – why not join them?   PatientView's Corporate Reputation of Pharma survey offers the opportunity to express your views on the pharmaceutical industry’s performance in 2024.    With just one month left until the survey closes, take a moment to participate and help shape the future of pharmaceutical and patient relationships.   https://lnkd.in/eS-x_xbj

Another example of a collaboration between pharma and patient groups is the initiative developed by Sick Cells and Pfizer to amplify patient voices through a US patient preference evidence program—helping pharma better understand the needs of those living with sickle cell disease.   Want the patient group voice heard? Take PatientView’s Corporate Reputation of Pharma survey and share your views on the industry in 2024/5 https://lnkd.in/eS-x_xbj

Queremos conocer la opinión de los grupos de pacientes de todo el mundo, especialmente de América Latina. PatientView te invita a dar tu opinión sobre la industria farmacéutica  👉  https://lnkd.in/eM9-BJrT Es momento de hacerte escuchar. Participa ahora  👉  https://lnkd.in/eM9-BJrT Tus respuestas son muy importantes para saber si las compañías farmacéuticas cumplieron con tus necesidades y expectativas en 2024 y para conocer tu opinión sobre lo que debería hacer la industria en 2025.       La encuesta es breve y puedes responderla de forma totalmente anónima. Te enviaremos una copia gratuita con los resultados del estudio, una vez que estos sean publicados. ¡Muchas gracias por participar!   #industriaFarmaceutica #pacientes #Latinamerica #Salud #medicina #medicamentos #cancer #diabetes #saludpublica

Over the next few days, we’ll be sharing examples of initiatives co-created by patient groups and pharma companies to improve patient care. The first example is the CDA Foundation and Gilead Sciences—their initiative puts patients with hepatitis B and C at the centre, ensuring better access to care and treatment.   Want pharma to better support your patient group? Share your insights in PatientView’s Corporate Reputation of Pharma survey and help shape the industry's future https://lnkd.in/eS-x_xbj  

PatientView’s ‘Pharma and ESG: The Patient Perspective’ report will be released on Friday, 28 February! Based on feedback and opinions from 700+ patient groups worldwide, this report explores their understanding of ESG and how pharma can better align with them on key environmental, social and governance issues. Stay tuned for valuable takeaways from this report.

Last year, over 2,500 patient groups worldwide shared their insights in PatientView’s Corporate Reputation of Pharma survey. Here are some of their names, including patient groups like Parkinson's UK, BreastCancer.org and Associazione Cefalea Ticino.   With just over a month left, this is your chance to have your say and help shape the future of healthcare.   The survey takes less than 15 minutes: https://lnkd.in/eS-x_xbj

PatientView’s Corporate Reputation of Pharma survey 2024/5 is now available in Arabic.    Click the link below to complete the interactive survey and have your say on the pharmaceutical industry’s performance and reputation in 2024.    https://lnkd.in/e_ddbvxd

Over 1000 patient groups worldwide have spoken – join them. PatientView’s Corporate Reputation of Pharma survey is your chance to share your insights on the pharmaceutical industry’s performance over the past year. With just over a month left, there’s still time to make your voice count! Take the survey and help shape the future of pharma and patient relationships: https://lnkd.in/eS-x_xbj.